文献速递妇科

卵巢癌减瘤术中机械性与口服抗生素肠道准备:我们是在降低还是仅仅交换了手术并发症?

Mechanical and oral antibiotic bowel preparation in ovarian cancer debulking: Are we lowering or just trading surgical complications?
PubMed 文献 · Gynecol Oncol · 2022-05-17

单机构回顾性研究纳入2011年1月至2020年12月接受肿瘤细胞减灭术的卵巢癌患者919例,其中215例(23.3%)行肠切除,81例(37.7%)术前接受机械性与口服抗生素肠道准备(MOABP)。校正分析显示MOABP患者深部/器官腔隙手术感染和30天再入院几率更低,但非计划ICU入住及3级及以上心脏和胃肠道并发症几率更高。

要点

  • 肠切除患者中37.7%接受MOABP,其深部/器官腔隙感染与30天再入院几率更低。
  • MOABP组非计划ICU入住及3级及以上心脏、胃肠道并发症几率更高。
  • MOABP组住院更短、造口更少、满意减瘤更多,但为单机构回顾性研究。

核心结论

  • 卵巢癌肿瘤细胞减灭术联合肠切除患者术前MOABP与深部/器官腔隙手术感染及30天再入院几率降低相关,但与非计划ICU入住及3级及以上心脏和胃肠道并发症几率升高相关。
  • 作者认为应在临床实践中权衡该人群术后的正面与负面结局。

研究设计与样本

  • 单机构回顾性研究,基于ICD-10诊断与手术操作编码纳入2011年1月至2020年12月接受肿瘤细胞减灭术的卵巢癌患者。
  • 共识别919例患者,215例(23.3%)行肠切除,其中81例(37.7%)接受MOABP。
  • 按是否行肠切除分层,肠切除患者再按是否行MOABP分层,采用未校正与校正logistic回归评估30天术后并发症几率。

主要发现

  • MOABP组与未行肠道准备组相比,间隔期肿瘤细胞减灭术比例更高(34.6% vs 9.0%)。
  • MOABP组满意手术切除比例更高(96.3% vs 83.8%),转流性造口更少(13.5% vs 33.5%),住院时间更短(7.1天 vs 9.4天)。
  • 校正分析中MOABP患者深部/器官腔隙手术感染及30天再入院几率显著更低,但非计划ICU入住及3级及以上心脏和胃肠道并发症几率更高。

临床怎么用

  • 作者认为该人群MOABP术后出现的正面与负面结局均应在临床实践中加以考虑。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To examine postoperative complications associated with preoperative mechanical and oral antibiotic bowel preparation (MOABP) for patients with ovarian cancer who underwent bowel resection at cytoreductive surgery (CRS). METHODS: This was a single-institution retrospective study of patients with ovarian cancer undergoing CRS from 01/2011-12/2020 using ICD-10 diagnoses and procedure codes. Patients were stratified by those who underwent bowel resection versus no resection. Bowel resection patients were further stratified by those who underwent MOABP versus no bowel preparation. Patient demographics, tumor data, and perioperative metrics were collected. Unadjusted and adjusted logistic regression evaluated odds of 30-day postoperative complications in patients with bowel resection versus no resection and those with MOABP versus no bowel preparation. RESULTS: Of 919 patients identified, 215 (23.3%) required bowel resection, which included 81 (37.7%) who received MOABP. Patient characteristics, co-morbidities, and cancer data were similar between MOABP versus no bowel preparation patients. MOABP patients underwent more interval CRS (34.6% versus 9.0%), more optimal surgical resections (96.3% versus 83.8%), fewer diverting ostomies (13.5% versus 33.5%), and shorter hospital stays (7.1 versus 9.4 days) than no bowel preparation patients. On adjusted analyses, MOABP patients experienced significantly lower odds of deep/organ-space surgical infections and 30-day readmissions but higher odds of unplanned intensive care unit (ICU) admissions and grade 3 or higher cardiac and gastrointestinal complications. CONCLUSIONS: Patients who underwent preoperative MOABP prior to ovarian cancer CRS with bowel resection had lower odds or deep/organ-space infections and readmissions, shorter hospital stays, fewer diverting ostomies, and more optimal resections. However, these patients also experienced higher odds of ICU admissions and grade 3 or higher cardiac and gastrointestinal complications. The positive and negative postoperative outcomes in this population should be considered in clinical practice.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Wang CC, Al-Rubaye R, Tran V, et al. Mechanical and oral antibiotic bowel preparation in ovarian cancer debulking: Are we lowering or just trading surgical complications? Gynecol Oncol. 2022. PMID: 35589434. doi:10.1016/j.ygyno.2022.05.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。